Asensus Surgical is acquired by KARL STORZ for $0.35 per share, merging to create a leading surgical robotics division.
Asensus Surgical announces signing of a definitive merger agreement with KARL STORZ, with KARL STORZ acquiring Asensus for $0.35 per share in cash. The deal is expected to create a leading surgical robotics division within KARL STORZ. Asensus Surgical will become a subsidiary of KARL STORZ Endoscopy-America and will no longer be publicly listed upon completion of the transaction in Q3.
June 07, 2024
4 Articles